Bilateral Implantation of enVista Envy Trifocal IOL for Cataract Patients
Official title: Evaluation of Visual Outcomes, Complications, and Neuroadaptation Following Bilateral Implantation of enVista Envy Trifocal Intraocular Lenses
Run by Pomeranian Medical University Szczecin · NCT07696130 · Data updated 2026-11-12
This study tests whether the enVista Envy trifocal intraocular lens can provide good distance, intermediate, and near vision after cataract surgery in adults who want less dependence on glasses.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 75 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Pomeranian Medical University Szczecin Academic / other |
| Locations | 1 site (Szczecin, Zachodnipomorskie) |
| Status | Recruiting |
| Started | February 1, 2026 |
| Main results expected | February 2029 |
| Study ends | February 2029 |
| Registry record updated | July 10, 2026 |
| Trial ID | NCT07696130 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with bilateral cataracts or prior refractive lens exchange, mild astigmatism, and motivation for spectacle independence.
✕Probably not a fit
Patients with certain eye diseases or ocular conditions may not benefit from the lens and could experience photic phenomena or limited improvement.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study investigates the safety and effectiveness of the enVista Envy trifocal intraocular lens implanted in both eyes during cataract or refractive lens exchange procedures. It focuses on visual outcomes, potential complications, and how patients adapt to the new lens. Eligible participants have bilateral cataracts or prior refractive lens replacement, minimal corneal astigmatism, and a strong desire for spectacle independence. Exclusion criteria include several ocular diseases and conditions that could affect vision or lens performance. The study is led by Pomeranian Medical University Szczecin and is based at the II Department of Ophthalmology in Szczecin, Poland.
Why it matters
Potential benefit: If successful, the lens could improve uncorrected vision at multiple distances and reduce the need for glasses after surgery.
How similar studies have gone: Other studies of diffractive trifocal IOLs have shown improvements in spectacle independence and high patient satisfaction, though results vary with individual eye anatomy.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Bilateral cataract or refractive lens exchange candidates. * Presbyopia and/or hyperopia. * Preoperative corneal astigmatism less than 1.00 diopter (D). * Absence of ocular diseases other than cataract. * High motivation to achieve spectacle independence. * Patients willing to accept the possibility of mild photic phenomena, such as glare and halos. Exclusion Criteria: * Ocular Conditions: * Glaucoma. * Amblyopia. * Macular diseases (including macular degeneration and other macular pathology). * Angle kappa greater than 0.5 mm. * Dry eye disease. * Corneal disorders. * Pupil abnormalities. * Irregular astigmatism. * Ocular motility disorders or strabismus. * Pupil diameter \< 2.5 mm under photopic conditions or \> 6.0 mm under mesopic conditions. * Abnormalities of the capsular bag or zonular apparatus, including pseudoexfoliation syndrome (PEX). * Lifestyle Factors: * Patients with unrealistic expectations regarding postoperative visual outcomes. * Individuals whose professions require highly precise visual performance, such as pilots, professional drivers, architects, or similar occupations. * Patients satisfied with using spectacles for near vision. * Age greater than 75 years (due to potential difficulties with neuroadaptation to new visual conditions). * Psychological and Personality Factors: * Patients with psychiatric disorders that may interfere with study participation or outcome assessment. * Patients dissatisfied with progressive addition lenses (progressive spectacles). * Patients with dyslexia or a history of stroke. * Type A personality traits (perfectionists). * Patients will also be excluded if the calculated IOL power falls outside the available range of +6.00 D to +34.00 D or if they have a history of laser vision correction surgery.
Where it's running
-
II Department of Ophthalmology, Pomeranian Medical University
Szczecin, Zachodnipomorskie, Poland Recruiting
Study contacts
- Study coordinator: Wojciech Lubiński
- Email: oko@pum.edu.pl
- Phone: +48 91 466 12 93
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Neuroplastic pain education and guided breathing during awake cataract surgery
This trial tests whether the STEIN Protocol, a non-drug approach with pain education, guided imagery, and paced breathing, helps adults having cataract surgery require less pain medicine and feel less anxious.
-
Rotational Stability of the Acunex Vario Toric
This study tests whether the Acunex Vario toric extended-depth-of-focus intraocular lens stays stable in rotation and effectively reduces astigmatism for people undergoing cataract surgery.
-
Anterior segment anatomy assessment with swept-source OCT in eye surgery patients
This study tests whether swept-source OCT can detail front-eye anatomy in patients undergoing anterior segment eye surgery.
-
MiLOOP-assisted cataract surgery for dense cataracts
In people with dense cataracts, this study tests whether using the miLOOP device during cataract surgery can protect corneal cells and reduce ultrasound energy, compared with standard surgery.
-
Vitreous Changes After Cataract Surgery
This study tests how the vitreous (the gel inside the eye) and its connection to the retina change after cataract surgery, using high-resolution eye scans before and after the procedure in people having cataract surgery who don’t have a posterior vitreous detachment at baseline.
-
Visual adaptation and quality of life after different IOL implantation options
This study follows adults who have cataracts and receive bilateral multifocal or mixed IOLs to see how their vision and daily life improve over 6 months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.